A Survival Analysis of Hypopharyngeal Cancer Patients: A Hospital-Cancer registry Based Study

被引:0
作者
Manigreeva Krishnatreya
Amal Chandra Kataki
Jagannath Dev Sharma
Nizara Baishya
Tashnin Rahman
Mouchumee Bhattcharyya
Ashok Kumar Das
Manoj Kalita
机构
[1] Dr B. Borooah Cancer Institute,Department of Cancer Epidemiology and Biostatistics
[2] Dr B. Borooah Cancer Institute,Patterns of Care and Survival Project
[3] Dr B. Borooah Cancer Institute,Department of Pathology
[4] Dr B. Borooah Cancer Institute,Hospital Based Cancer Registry
[5] Dr B. Borooah Cancer Institute,National Cancer Registry Programme
[6] Dr B. Borooah Cancer Institute,Department of Head and Neck Oncology
[7] Dr B. Borooah Cancer Institute,Department of Radiation Oncology
来源
Indian Journal of Otolaryngology and Head & Neck Surgery | 2019年 / 71卷
关键词
Chemotherapy; Hypopharynx; Radiotherapy; Survival;
D O I
暂无
中图分类号
学科分类号
摘要
To study the survival in patients affected with hypopharyngeal cancer among treatment groups and different stages. Data of hypopharyngeal cancer patients diagnosed from 1st January 2010 to 31st December 2010 was used in the present study. The cases were analyzed for gender, age group distribution, sub-sites at presentation, stage at diagnosis and the type of treatments. Survival from the date of first diagnosis was estimated and hazard ratios were calculated. Survival probability and hazards ratios (HR) were calculated by Kaplan–Meier method and Cox-proportional regression analysis respectively. Censoring of patient who survived longer than 5 years was done. Active follow-up was done for the survival analysis. The study cohort included 217 patients and treatment compliance was observed in 46.9% of cases. The median age at diagnosis was 57 years (range 24–90), 86.2% of cases were locally advanced cases (stage III and IV), pyriform sinus was major sub-site (96%), radiotherapy was main treatment modality alone in 84.8% of cases, median survival was 31 months and 5-year overall survival was 36.9%, and HR for stage IV was 1.9 (P = 0.03, 95% CI − 1.04 to 3.7). In developing setting of North East India, radiotherapy was the main modality of treatment for hypopharyngeal cancer patients, and understanding the clinical parameters and survival of this group of cancers is crucial for its control.
引用
收藏
页码:798 / 804
页数:6
相关论文
共 154 条
[1]  
Kuo P(2014)Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States Laryngoscope 124 2064-2069
[2]  
Chen MM(2015)Radiotherapy and concurrent chemo-radiotherapy in locally advanced hypopharyngeal cancers—a hospital registry based analysis Asian Pac J Cancer Prev 16 4723-4726
[3]  
Decker RH(2015)Clinical characteristics of 97 hypopharyngeal carcinoma cases Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 29 542-546
[4]  
Yarbrough WG(2009)Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches Acta Oncol 48 541-548
[5]  
Judson BL(2008)Results after intensified therapy for advanced carcinoma of the hypopharynx Ear Nose Throat J 87 E11-957
[6]  
Sharma JD(2007)Functional outcomes following total laryngopharyngectomy ANZ J Surg 77 954-160
[7]  
Krishnatreya M(2009)Factors affecting results of treatment of hypopharyngeal carcinoma Hippokratia 13 154-629
[8]  
Das AK(2015)Survival trends in hypopharyngeal cancer: a population-based review Laryngoscope 125 624-773
[9]  
Bhatacharyya M(2016)Randomized clinical trials and observational studies: Is there a battle? J Clin Oncol 34 772-53
[10]  
Hazarika M(2016)Definitive chemoradiotherapy versus surgery followed by adjuvant radiotherapy in resectable stage III/IV hypopharyngeal cancer Cancer Res Treat 48 45-108